Compositions:
Oflobid tablets 200 mg
Each film coated tablets contains; ofloxacin 200 mg, oflobid 400 mg.
Each tablets coated contanis, ofloxacin 400 mg.
Indications:
Acute, chronic or recurrent tract infections caused by Haemophilus influenza or other Gramnegtive or multi resistant pathogens, as well as staphylococcus aureus. pneumonias, especially if caused by problem pathogens such as escherichiacoli, klebsiella, enterobacter, prottus, pseudomonas, legionella or staphylococcus.
Chronic and recurrent infections of ear, nose and throat, especially if caused by Gram- negative pathogens including pseudomonas, by staphylococcus. Infections of soft tissue and skin. Infection of bone and joints, Infections of the abdominal cavity, including the palvis minor, and bacterial entries. Infections of the kidney, urinary tract, genital organs and gonorrhea.
Antibacterial Spectrum:
The following microorganisms may be regarded as susceptible:
staphylococcus aureus, staphylococcus epidermidis, neisseria gonorrhoea, neisseria meningitidis, escherichia, citrobactor, hafnia, proteus, salmonella, shigella, yersinia,and legionella.
Contra-indications:
Oflobid should not be used in patients hypersensitive to ofloxacin or quinolones. Oflobis is contraindications in epileptics.
Oflobis must not be used in patients with pre- existing central nervous sysytem lesions involving a lowered convulsion threshed. After cerebrocranial injuries in the region of the central nervous system or stroke. In children or adolescents in the growth phase and in- pregnant or breast feeding women, Oflobid is not indicated because the safe use in such patients has not yet been sufficient documented and judging from animal experiments the risk of damage to the cartilage of joint in the growing organism cannot be altogether excludeed.
Adverse Reaction:
Oflobid may produce the following undesirable adverse effects. Gastrointestinal tract, Stomach upsets, abdominal pain, loss of appetite, nausea,vomiting, diarrhea.
Dosage and Administrations:
Dosage depends on the type and severity of the infections.
Administrations:
Oflobid should be swallowed un chewed with some liquid. It may be taken an empty stomach or with meal. The duration of treatment depends on the response of the causative organism and the clinical picture.
Storage and Stability:
Keep medicines out of the reach of children. Store in a cool and dry place, protect from sunlight.
Oflobid tablets 200 mg
Each film coated tablets contains; ofloxacin 200 mg, oflobid 400 mg.
Each tablets coated contanis, ofloxacin 400 mg.
Indications:
Acute, chronic or recurrent tract infections caused by Haemophilus influenza or other Gramnegtive or multi resistant pathogens, as well as staphylococcus aureus. pneumonias, especially if caused by problem pathogens such as escherichiacoli, klebsiella, enterobacter, prottus, pseudomonas, legionella or staphylococcus.
Chronic and recurrent infections of ear, nose and throat, especially if caused by Gram- negative pathogens including pseudomonas, by staphylococcus. Infections of soft tissue and skin. Infection of bone and joints, Infections of the abdominal cavity, including the palvis minor, and bacterial entries. Infections of the kidney, urinary tract, genital organs and gonorrhea.
Antibacterial Spectrum:
The following microorganisms may be regarded as susceptible:
staphylococcus aureus, staphylococcus epidermidis, neisseria gonorrhoea, neisseria meningitidis, escherichia, citrobactor, hafnia, proteus, salmonella, shigella, yersinia,and legionella.
Contra-indications:
Oflobid should not be used in patients hypersensitive to ofloxacin or quinolones. Oflobis is contraindications in epileptics.
Oflobis must not be used in patients with pre- existing central nervous sysytem lesions involving a lowered convulsion threshed. After cerebrocranial injuries in the region of the central nervous system or stroke. In children or adolescents in the growth phase and in- pregnant or breast feeding women, Oflobid is not indicated because the safe use in such patients has not yet been sufficient documented and judging from animal experiments the risk of damage to the cartilage of joint in the growing organism cannot be altogether excludeed.
Adverse Reaction:
Oflobid may produce the following undesirable adverse effects. Gastrointestinal tract, Stomach upsets, abdominal pain, loss of appetite, nausea,vomiting, diarrhea.
Dosage and Administrations:
Dosage depends on the type and severity of the infections.
Administrations:
Oflobid should be swallowed un chewed with some liquid. It may be taken an empty stomach or with meal. The duration of treatment depends on the response of the causative organism and the clinical picture.
Storage and Stability:
Keep medicines out of the reach of children. Store in a cool and dry place, protect from sunlight.
microtouch solo titanium - www.titanium-arts.com
ReplyDeleteWe are the microtouch titanium only MicroTouch casino on the titanium armor market. tube supplier Play with confidence now for titanium mens rings free. microtouch, Microtouch, Microtouch, Microtouch, Microtouch, how strong is titanium Microtouch, Microtouch